NF2

Clinical trials for NF2 explained in plain language.

Never miss a new study

Get alerted when new NF2 trials appear

Sign up with your email to follow new studies for NF2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New pill tested for rare brain tumor disorder

Disease control Not yet recruiting

This early-stage study is testing a new oral medication called PRG-N-01 for adults with Neurofibromatosis Type II (NF2), a genetic condition that causes non-cancerous tumors along nerves. The main goals are to find the safest and most effective dose and to see if the drug can shr…

Matched conditions: NF2

Phase: PHASE1, PHASE2 • Sponsor: PRG Science & Technology Co., Ltd. • Aim: Disease control

Last updated Mar 16, 2026 15:23 UTC

NF2

Get alerted when new NF2 trials appear

New pill tested for rare brain tumor disorder